The Cancer Letter

Inside information on cancer research and drug development

Vol.
37
No.
29
July 22, 2011Jul 22, 2011
Free
DOWNLOAD THE PDF

A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review

Part One Of A Two-Part Interview With NCI Director Harold Varmus

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

Richard Pazdur’s Comments to ODAC

Department of Defense Offering $16 Million in Cancer Research Grants

Login

Site license subscribers:
Log in with your IP | Register a sponsored account